Based on 20 analysts giving stock ratings to Privia Health Group Inc in the past month.
In the current month, PRVA has received 12 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PRVA average Analyst price target in the last month is 31.471.
Based on analysts' estimates, PRVA EPS is projected to reach 0.092 in FY2026Q3, following reported EPS of 0.072 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.07, while Privia Health Group IncPRVA's earnings per share (EPS) for the previous quarter was USD 0.02. EPS for the next quarter is expected at USD 0.09.